Page last updated: 2024-11-04

sulfadiazine and Jejunal Diseases

sulfadiazine has been researched along with Jejunal Diseases in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.

Research Excerpts

ExcerptRelevanceReference
"A rabbit serosal scarification model was utilized to compare the ability of four drugs, previously administered peri-operatively to horses undergoing exploratory celiotomy, to prevent the development of postoperative intestinal adhesions."1.29Utilization of the serosal scarification model of postoperative intestinal adhesion formation to investigate potential adhesion-preventing substances in the rabbit. ( Barker, IK; Conlon, PD; Hurtig, MB; Livesey, MA; Singer, ER, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singer, ER1
Livesey, MA1
Barker, IK1
Hurtig, MB1
Conlon, PD1

Other Studies

1 other study available for sulfadiazine and Jejunal Diseases

ArticleYear
Utilization of the serosal scarification model of postoperative intestinal adhesion formation to investigate potential adhesion-preventing substances in the rabbit.
    Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 1996, Volume: 60, Issue:4

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Carboxymeth

1996